BRIEF published on 01/28/2026 at 18:53, 6 days 15 hours ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/23/2026 at 19:05, 11 days 15 hours ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
BRIEF published on 01/23/2026 at 19:05, 11 days 15 hours ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
PRESS RELEASE published on 01/23/2026 at 19:00, 11 days 15 hours ago Inside Information / Other news releases ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
BRIEF published on 01/07/2026 at 19:17, 27 days 15 hours ago ABIONYX Pharma's Half-Yearly Review of Liquidity Contract Liquidity Contract TP ICAP Europe Stock Market Transactions ABIONYX Pharma Stocks And Cash
PRESS RELEASE published on 01/07/2026 at 19:12, 27 days 15 hours ago Inside Information / Other news releases ABIONYX Pharma releases half-yearly report on liquidity contract with TP ICAP (Europe) SA, detailing shares and cash balance for 2025 Liquidity Contract Shares TP ICAP Cash Balance ABIONYX Pharma
BRIEF published on 12/16/2025 at 21:23, 1 month 18 days ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 1 month 18 days ago ABIONYX Pharma Announces €1.8 Million Capital Increase Capital Increase Subscription Rights Euronext Listing ABIONYX Pharma Financial Visibility
PRESS RELEASE published on 12/16/2025 at 21:18, 1 month 18 days ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
BRIEF published on 12/05/2025 at 18:05, 1 month 29 days ago ABIONYX Reports Monthly Voting Rights and Share Data Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
Published on 02/04/2026 at 02:15, 8 hours 2 minutes ago Future Fuels Announces $2 Million LIFE Flow-Through Offering
Published on 02/04/2026 at 00:00, 10 hours 17 minutes ago Sintana Energy Inc. Announces VMM-37 Resolution
Published on 02/03/2026 at 23:30, 10 hours 47 minutes ago FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 11 hours 5 minutes ago Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 11 hours 47 minutes ago Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million
Published on 02/04/2026 at 10:05, 12 minutes ago Huawei to Launch Innovative New Products in Madrid, Showcasing a Dazzling Lineup
Published on 02/04/2026 at 10:05, 12 minutes ago Acwa Appoints Thinkproject as Strategic Digital Partner to Accelerate Global Strategy and Asset Digitisation
Published on 02/04/2026 at 10:00, 17 minutes ago Invitation to the Conference Call for Investors, Analysts and Media
Published on 02/04/2026 at 09:17, 59 minutes ago IBU-tec: Research project develops a concept for dry coating on an industrial scale using IBUvolt® LFP400
Published on 02/04/2026 at 09:00, 1 hour 16 minutes ago Original-Research: MHP Hotel AG (von NuWays AG): BUY
Published on 02/03/2026 at 08:00, 1 day 2 hours ago EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 1 day 2 hours ago Neoen launches three new solar farms in France with a total capacity of 230 MWp
Published on 02/02/2026 at 18:23, 1 day 15 hours ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 1 day 16 hours ago Covivio - Information on total number of voting rights and share capital
